{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New Paltz",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89464",
      "recalling_firm": "Ultra Seal Corporation",
      "address_1": "521 Main St",
      "address_2": "N/A",
      "postal_code": "12561-1609",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0468-2022",
      "product_description": "CHLORESIN (acetaminophen 325mg, dextromethorphan HBr 15mg, Guaifenesin 200mg, Phenylephrine HCl 5mg) 2 tablet packets, Manufactured For Afassco Inc. Minden NV 89423, NDC 51532-0107-2",
      "product_quantity": "225,350 packets",
      "reason_for_recall": "cGMP deviations",
      "recall_initiation_date": "20220124",
      "center_classification_date": "20220131",
      "termination_date": "20231016",
      "report_date": "20220209",
      "code_info": "Lot #: AK9492, Exp. Date 02/2022"
    }
  ]
}